IAPP and Alzheimer disease: Although the need to quantify molecular amylin-Aβ interaction in human AD has been recognized (9, 10, 11, 12, 13), the complexity and lack of scalability of traditional methods (such as immunoprecipitation, Western blot, circular dichroism, and electron microscopy) have hampered studies requiring larger sample sizes.